CORRECTION: I am NOT investing in SDVI Here's my post

New Post Public Reply Private Reply Replies (0) Message Board
joey68 joey68 #268
267
CORRECTION : I am NOT investing in SDVI

Here's my post why:

http://investorshangout.com/post/view?id=4319789

In addition, ICNB is an almost guaranteed winner. Id rather put my money in a stock I know will climb; compared to a stock which may climb

There are 8,000+ securities in the OTC. Its impossible to get in all of them. Therefore, ICNB is my best bet. If you want to invest in SDVI, do it. Doesnt matter to me either way.
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Victor Care Networks Explores Transformative Mental Health

Updated Category News Views 3

Connections at the Core of Care Victor Care Network is stepping into the spotlight with a feature on "All Access hosted by Andy Garcia," putting human relationships front and center in mental health support. This ain't just another run-of-the-mill initiative—it’s a deep dive into the bonds that help people when the chips are down. So, what's it all about? Helping...

Continue Reading
Allooloo's AI Zones Transform Financial Services Agent

Updated Category News Views 3

The Allure of AI Agents in Finance Ah, it's a brave new world, my friend. A hundred years ago, the financial services industry relied on flesh-and-blood analysts armed with pens and filing cabinets. Today? It's all about AI agents, and Allooloo Technologies Corp. is at the heart of the action. Just recently, they rolled out specialized zones of record for AI—datasets...

Continue Reading
Honeywell Aerospace Faces Investor Class Action Lawsuit

Updated Category News Views 5

Smoke and Mirrors: Honeywell's Legal Trouble Okay, here's a fun way to start your day: talking lawsuits. Honeywell Aerospace Inc. (NASDAQ:HONA), a name you'd know if you're into aircraft components and avionics, is in hot water. It seems they've been less than transparent about their business prospects, prompting a class action lawsuit from open market purchasers during a...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 3

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Amber Intl Unveils AGM Outcomes, Strategic Moves

Updated Category News Views 2

Diving Into Amber International's AGM Decisions Ah, the hum of shareholder meetings—a fancy little dance of approvals and resolutions! That's exactly what went down on October 23, 2026, for Amber International Holding Limited. A fresh roster, some hefty share awards, and strategic decisions wrapped up their recent annual gathering. Shed the lawyer-speak and let's get...

Continue Reading
Graybar's Integrity Shines: Forbes Honors Trust Again

Updated Category News Views 3

Trust Is Graybar's Secret Sauce Graybar's been hauling the trust trophy back home from Forbes for the second year straight. This ain't just another fleeting accolade—the kind you hang on the office wall without meaning it. What's brewing here is more profound, nestled in the heart of St. Louis and bubbling through its logistics veins. Being named one of Forbes' 2027...

Continue Reading
Oakworth Capital's Strategic Gains: A Deep Dive

Updated Category News Views 2

Oakworth Capital's Big Moves This Quarter Diving right into the Alabama-based Oakworth Capital's latest numbers, they did not pull any punches with a hefty 19% bump in net income. Now, in a world where banking can sometimes feel like riding a porcupine, Oakworth's ability to rise above speaks volumes. They clocked in at $17.2 million net income for the year-to-date period...

Continue Reading
Cole Haan Opens 600th Store, Makes Boston Comeback

Updated Category News Views 6

A Milestone and a Homecoming Who would've thought? Cole Haan, the American staple that seems to draw from an old-world charm and modern flair, is making waves again. They've just hit their 600th store mark—a number not to scoff at, especially when retail's felt the squeeze lately. But it’s not just about another number. It’s about a return, a resounding "we still...

Continue Reading
Sivers Semiconductors Shakes Up Auditors and Incentives

Updated Category News Views 5

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Continue Reading

Top 5 Most Recently Viewed Articles

Avanos Medical Appoints Camille Chang Gilmore as HR Leader

Updated Category News Views 231

Avanos Medical Welcomes Camille Chang Gilmore Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the medical technology industry renowned for its innovative healthcare solutions, is excited to share the news of Camille Chang Gilmore's appointment as Senior Vice President and Chief Human Resources Officer. This strategic decision underscores Avanos' commitment to...

Continue Reading
Unlocking Efficiency in Convenience Stores with Square 9

Updated Category News Views 152

Empowering Convenience Stores to Thrive The convenience store industry is experiencing robust growth, presenting both opportunities and challenges for business owners. Amidst this evolving landscape, Square 9 Softworks steps up as a knowledgeable ally, offering powerful insights through its latest expert guide designed specifically for C-stores. This essential resource...

Continue Reading
CREATEA Launches Innovative Mighty Mango Beverage Concept

Updated Category News Views 256

Unveiling of CREATEA Mighty Mango Concept Beverage CREATEA is set to turn heads with the introduction of its Mighty Mango beverage at SupplySide Global 2025. This innovative drink combines a unique formula that not only promotes physical performance through creatine but also enhances mental energy with scientifically-supported ingredients. The 12 oz ready-to-drink...

Continue Reading
Performance Brokerage Services Facilitates Mark Chevrolet Sale

Updated Category News Views 204

Performance Brokerage Services Facilitates Dealership Sale Performance Brokerage Services, a leader in dealership buy-sell activities, recently announced the successful sale of Mark Chevrolet. The transition involved Charles Cabana, the former owner, and Bill Golling, associated with the prominent Golling Automotive Group. A Legacy of Service at Mark Chevrolet Mark...

Continue Reading
Dillard's Stock Takes a Hit: Key Insights and Trends

Updated Category News Views 153

Stock Slump: What Gives? Look, I’ve been in this game long enough to know when a company’s got its back against the wall. Dillard’s is feeling the heat, and today it’s clear: the department store operator isn’t exactly riding high on the hog. Their stock, Dillard's (DDS), took a nosedive of 7.18% and is sitting at $599.80. Why? Well, it boils down to mixed...

Continue Reading